SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. is trending due to the completion of its merger with Strive Enterprises, with the community anticipating a short squeeze and discussing the potential impact of the new CUSIP.  Bulls are excited about Strive's focus on Bitcoin investment and the possibility of a significant funding pipeline, while some traders highlight the high short interest and potential for dark pool manipulation. Chatter revolves around the potential for a substantial price increase and speculation about margin calls on Monday.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the community anticipates potential ETF approvals and discusses bullish technical patterns. Talk centers around XRP's strength and potential for significant price movement, with some drawing comparisons to previous rallies. The community remains focused on XRP's long-term prospects and utility in the financial sector.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station's IPO is trending as traders discuss its potential amidst the crypto run, with some citing bullish outlooks and others pointing to the company's losses. Community sentiment is mixed, with some questioning the valuation and others comparing it to other recent IPOs. The stock's initial volatility and trading halts are also key discussion points.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

aTyr Pharma ($ATYR) is trending due to anticipation surrounding its upcoming Phase 3 data release for Efzofitimod, a treatment for pulmonary sarcoidosis. The community is actively discussing potential outcomes, with some speculating about leaked data and a possible short squeeze given the high short interest, while others are focused on the potential impact of positive results on the company's broader platform and future indications.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending amid discussions of potential catalysts and technical levels, with community members debating whether the recent surge is sustainable or a short squeeze. Some speculate about Elon Musk's influence and potential impact of new ventures, while others point to challenges in the EV market and the company's valuation. The stock's significant price movement is fueling both bullish enthusiasm and bearish skepticism.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending amid discussions around the implications of potential shifts in government policy regarding COVID-19 vaccines, including concerns about linking vaccines to child deaths. The community is weighing the potential impact on Pfizer's revenue and future prospects, with some questioning liability and others pointing to the company's broader pipeline beyond vaccines. Additionally, some traders are closely monitoring technical indicators and dividend payouts, viewing the dip as a possible buying opportunity.

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

GlucoTrack Inc

Fueled by news of a recent investment agreement, GCTK is experiencing significant after-hours momentum, with community members highlighting its low float and potential for a multi-day run. Some traders are drawing comparisons to other high-flying stocks and anticipating a potential short squeeze, while others urge caution due to the stock's volatility.

Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending. The Office segment consists of the rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment involves the operation of hotel properties. The Lending segment focuses on loans to small businesses. The company was founded in 1993 and is headquartered in Dallas, TX.

Creative Media & Community Trust

CMCT is trending as traders discuss its potential for a short squeeze, citing its low float and recent price action. Community members are speculating on news and some anticipate a run to fill a previous gap. Others point to the company's fundamentals and note a reverse split is on the horizon.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending downwards as reports circulate that the Trump administration may link COVID-19 vaccines to child deaths, creating uncertainty around the stock's future. The community is discussing the potential impact of this news, while some investors see a buying opportunity due to the perceived overreaction and low valuation. Discussions also include Moderna's pipeline beyond COVID-19, especially its personalized cancer vaccine program.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to regulatory approval of its Oxford Ionics acquisition, sparking discussions about its long-term impact and potential catalysts. Community chatter includes debates on valuation, future government contracts, and comparisons to other quantum computing firms. Bullish sentiment highlights the company's technology and market position, while bears express concerns about profitability and competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Chipotle's Expansion Beyond North America Deliver Growth?

CMG is betting on global growth with strong gains in Canada, Europe and the Middle East.

Dutch Bros (BROS) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Dutch Bros (BROS) closed at $66.5, marking a +2.26% move from the previous day.

Dutch Bros' Traffic and Ticket Growth, Sustainable or Short-Lived?

BROS posts 28% revenue growth with rising transactions and loyalty-driven sales, but questions loom on its staying power.


Is Dutch Bros (BROS) Stock Outpacing Its Retail-Wholesale Peers This Year?

Here is how Dutch Bros (BROS) and Urban Outfitters (URBN) have performed compared to their sector so far this year.

Wall Street Analysts Think Dutch Bros (BROS) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for Dutch Bros (BROS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

BROS Up 23% in a Month, Valuation Stretched: How to Play the Stock?

Dutch Bros stock is up nearly 23% in a month as strong traffic, new shops, and expansion plans fuel growth despite a premium valuation.


BABA Q1 Earnings Miss Estimates, Revenues Increase Y/Y, Shares Rise

Alibaba leans into AI and cloud, but Q1 earnings miss and falling margins reveal growing costs behind future bets.

Dutch Bros Bets on New Markets: Will Traffic Trends Keep Up?

BROS' rapid expansion and strong comps fuel growth, but sustaining traffic momentum as competition heats up is the key test ahead.


Starbucks vs. Dutch Bros: Which Coffee Stock is a Better Buy Now?

BROS' rapid shop growth, youth-focused brand, and rising estimates give it the edge over SBUX in the evolving coffee market.

Dutch Bros (BROS) Crossed Above the 200-Day Moving Average: What That Means for Investors

Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Current Price	$64.55
Prev Close	$66.50
Open	$66.19
Dividend Yield	0.00%
50-Day Moving Average	$64.85
Beta	1.54
Avg. Volume	4.27M
PE Ratio	141.22

52-Week High	$86.88
52-Week Low	$30.49
Market Capitalization	$8.44B
EPS (Annual)	$0.3386
Price to Book	13.27
Revenue Per Employee	$49,269.81
Enterprise Value/EBITDA	N/A

BROS
Dutch Bros Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BROS News

BROS Dutch Bros Inc